Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Harcharik

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Skin Therapy Letter|February 27, 2014
Steroid-sparing properties of emollients in dermatologySara Harcharik, Jason Emer
JAAD Case Reports|February 2, 2018
Balanitis associated with FOLFIRI chemotherapyGoran Micevic, Sara Harcharik Perkins, Amanda E Zubek
Cutis|November 13, 2015
An analysis of the clinical trial landscape for cutaneous melanomaSara Harcharik Perkins, Kristian D Stensland, Matthew D Galsky, et al.
The Clinical Teacher|September 13, 2014
Instructional video for teaching venepunctureMichael Pan, Sara Harcharik, Marina Moskalenko, et al.
Journal of the American Academy of Dermatology|October 31, 2024
Characterization of electronic medical record patient portal messaging and the impact of the COVID-19 pandemic: A single institution experienceChristine Hodelin, Jolanta J Pach, Maria Tomas Gracia, et al.
The Journal of Investigative Dermatology|January 29, 2014
Decreased expression of the chromatin remodeler ATRX associates with melanoma progressionZulekha A Qadeer, Sara Harcharik, David Valle-Garcia, et al.
Melanoma Research|December 25, 2012
Elevated rates of transaminitis during ipilimumab therapy for metastatic melanomaSebastian G Bernardo, Marina Moskalenko, Michael Pan, et al.
Oncolytic Virotherapy|August 12, 2016
Oncolytic virus therapy for cancerJoe Goldufsky, Shanthi Sivendran, Sara Harcharik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2014
Blood mRNA expression profiling predicts survival in patients treated with tremelimumabYvonne Saenger, Jay Magidson, Bobby Liaw, et al.
Journal of the American Academy of Dermatology|April 5, 2014
Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanomaSara Harcharik, Sebastian Bernardo, Marina Moskalenko, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Skin Therapy Letter|February 27, 2014
Steroid-sparing properties of emollients in dermatologySara Harcharik, Jason Emer
JAAD Case Reports|February 2, 2018
Balanitis associated with FOLFIRI chemotherapyGoran Micevic, Sara Harcharik Perkins, Amanda E Zubek
Cutis|November 13, 2015
An analysis of the clinical trial landscape for cutaneous melanomaSara Harcharik Perkins, Kristian D Stensland, Matthew D Galsky, et al.
The Clinical Teacher|September 13, 2014
Instructional video for teaching venepunctureMichael Pan, Sara Harcharik, Marina Moskalenko, et al.
Journal of the American Academy of Dermatology|October 31, 2024
Characterization of electronic medical record patient portal messaging and the impact of the COVID-19 pandemic: A single institution experienceChristine Hodelin, Jolanta J Pach, Maria Tomas Gracia, et al.
The Journal of Investigative Dermatology|January 29, 2014
Decreased expression of the chromatin remodeler ATRX associates with melanoma progressionZulekha A Qadeer, Sara Harcharik, David Valle-Garcia, et al.
Melanoma Research|December 25, 2012
Elevated rates of transaminitis during ipilimumab therapy for metastatic melanomaSebastian G Bernardo, Marina Moskalenko, Michael Pan, et al.
Oncolytic Virotherapy|August 12, 2016
Oncolytic virus therapy for cancerJoe Goldufsky, Shanthi Sivendran, Sara Harcharik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2014
Blood mRNA expression profiling predicts survival in patients treated with tremelimumabYvonne Saenger, Jay Magidson, Bobby Liaw, et al.
Journal of the American Academy of Dermatology|April 5, 2014
Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanomaSara Harcharik, Sebastian Bernardo, Marina Moskalenko, et al.
Pageof 1